: Charles Y. Kuo
- Charles Y. Kuo first started conducting FDA inspections in 2023, with the last inspection in 2024. Over that time, Charles Y. Kuo has conducted 5 inspections at 5 companies across 5 sites.
Get Charles Kuo's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Catalent Indiana, Bloomington | November 2023
Available Now - $199
Charles Y. Kuo
Human Drugs Form 483
FDA 483 AGC Biologics, Bothell | February 2023
Available Now - $199
Charles Y. Kuo
Human Drugs Form 483
FDA 483 CSL Behring GmbH, Marburg | 2024
Out-of-stock
Charles Y. Kuo
Human Drugs Form 483
FDA 483 Rentschler Biopharma Inc., Milford | 2023
Out-of-stock
Charles Y. Kuo
Human Drugs Form 483
FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2023
Out-of-stock
Charles Y. Kuo
Human Drugs Form 483
Co-Investigators (11)
- Richard Ledwidge, FDA Investigator
- Alan L. Truong, FDA Investigator
- Rafeeq A. Habeeb, FDA Investigator
- Jacob G. Lutz, FDA Investigator
- Andrew J. Barrowcliff, FDA Investigator
- Wendy G. Tan, FDA Investigator
- Yuan-Chia Kuo, FDA Investigator
- Zhong Li, FDA Investigator
- Michael Araneta, FDA Investigator
- Andrew K. Haack, FDA Investigator
- Jee Y. Chung, FDA Investigator